Alloxan-glucose interaction

Effect on incorporation of14C-leucine into pancreatic islets of rat

Renu Bansal, Nafees - Ahmad, Jalil R. Kidwai

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The acute effect of alloxan on the incorporation of14C-leucine into isolated rat islets of Langerhans was studied. I.v. administration of alloxan (40 mg/kg body weight) in rats inhibited the subsequent in vitro incorporation of14C-leucine into (pro-)insulin in the isolated islets. Glucose (750 mg/kg body weight), when administered 5 min prior to alloxan, completely protected the islets against alloxan toxicity. The protective effect of glucose was partly reversed when the concentration of alloxan was raised to 80 mg/kg body weight. Similar results of inhibition of (pro-)insulin biosynthesis by alloxan and its protection by glucose were obtained when isolated rat islets were exposed to alloxan and/or glucose in vitro. Islets exposed to glucose in vitro immediately after alloxan exposure showed a slower rate of inhibition of (pro-)insulin biosynthesis, as compared to islets washed before exposure to D-glucose. In view of these findings, it is suggested that there is a common recognition site on B-cell for alloxan and glucose.

Original languageEnglish (US)
Pages (from-to)135-143
Number of pages9
JournalActa Diabetologica Latina
Volume17
Issue number2
DOIs
StatePublished - Apr 1980
Externally publishedYes

Fingerprint

Alloxan
Islets of Langerhans
Leucine
Glucose
Body Weight
Insulin
B-Lymphocytes

Keywords

  • (Pro-) insulin
  • Alloxan
  • D-glucose
  • Islets of Langerhans
  • Pancreas

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Alloxan-glucose interaction : Effect on incorporation of14C-leucine into pancreatic islets of rat. / Bansal, Renu; Ahmad, Nafees -; Kidwai, Jalil R.

In: Acta Diabetologica Latina, Vol. 17, No. 2, 04.1980, p. 135-143.

Research output: Contribution to journalArticle

@article{70b04ad0e9ac455a843afd13fdfe4629,
title = "Alloxan-glucose interaction: Effect on incorporation of14C-leucine into pancreatic islets of rat",
abstract = "The acute effect of alloxan on the incorporation of14C-leucine into isolated rat islets of Langerhans was studied. I.v. administration of alloxan (40 mg/kg body weight) in rats inhibited the subsequent in vitro incorporation of14C-leucine into (pro-)insulin in the isolated islets. Glucose (750 mg/kg body weight), when administered 5 min prior to alloxan, completely protected the islets against alloxan toxicity. The protective effect of glucose was partly reversed when the concentration of alloxan was raised to 80 mg/kg body weight. Similar results of inhibition of (pro-)insulin biosynthesis by alloxan and its protection by glucose were obtained when isolated rat islets were exposed to alloxan and/or glucose in vitro. Islets exposed to glucose in vitro immediately after alloxan exposure showed a slower rate of inhibition of (pro-)insulin biosynthesis, as compared to islets washed before exposure to D-glucose. In view of these findings, it is suggested that there is a common recognition site on B-cell for alloxan and glucose.",
keywords = "(Pro-) insulin, Alloxan, D-glucose, Islets of Langerhans, Pancreas",
author = "Renu Bansal and Ahmad, {Nafees -} and Kidwai, {Jalil R.}",
year = "1980",
month = "4",
doi = "10.1007/BF02580995",
language = "English (US)",
volume = "17",
pages = "135--143",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia",
number = "2",

}

TY - JOUR

T1 - Alloxan-glucose interaction

T2 - Effect on incorporation of14C-leucine into pancreatic islets of rat

AU - Bansal, Renu

AU - Ahmad, Nafees -

AU - Kidwai, Jalil R.

PY - 1980/4

Y1 - 1980/4

N2 - The acute effect of alloxan on the incorporation of14C-leucine into isolated rat islets of Langerhans was studied. I.v. administration of alloxan (40 mg/kg body weight) in rats inhibited the subsequent in vitro incorporation of14C-leucine into (pro-)insulin in the isolated islets. Glucose (750 mg/kg body weight), when administered 5 min prior to alloxan, completely protected the islets against alloxan toxicity. The protective effect of glucose was partly reversed when the concentration of alloxan was raised to 80 mg/kg body weight. Similar results of inhibition of (pro-)insulin biosynthesis by alloxan and its protection by glucose were obtained when isolated rat islets were exposed to alloxan and/or glucose in vitro. Islets exposed to glucose in vitro immediately after alloxan exposure showed a slower rate of inhibition of (pro-)insulin biosynthesis, as compared to islets washed before exposure to D-glucose. In view of these findings, it is suggested that there is a common recognition site on B-cell for alloxan and glucose.

AB - The acute effect of alloxan on the incorporation of14C-leucine into isolated rat islets of Langerhans was studied. I.v. administration of alloxan (40 mg/kg body weight) in rats inhibited the subsequent in vitro incorporation of14C-leucine into (pro-)insulin in the isolated islets. Glucose (750 mg/kg body weight), when administered 5 min prior to alloxan, completely protected the islets against alloxan toxicity. The protective effect of glucose was partly reversed when the concentration of alloxan was raised to 80 mg/kg body weight. Similar results of inhibition of (pro-)insulin biosynthesis by alloxan and its protection by glucose were obtained when isolated rat islets were exposed to alloxan and/or glucose in vitro. Islets exposed to glucose in vitro immediately after alloxan exposure showed a slower rate of inhibition of (pro-)insulin biosynthesis, as compared to islets washed before exposure to D-glucose. In view of these findings, it is suggested that there is a common recognition site on B-cell for alloxan and glucose.

KW - (Pro-) insulin

KW - Alloxan

KW - D-glucose

KW - Islets of Langerhans

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=0019130634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019130634&partnerID=8YFLogxK

U2 - 10.1007/BF02580995

DO - 10.1007/BF02580995

M3 - Article

VL - 17

SP - 135

EP - 143

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 2

ER -